(Q34901567)

English

Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Optimizing nasal potential difference analysis for CFTR modulator development: assessment of ivacaftor in CF subjects with the G551D-CFTR mutation (English)

1 reference

Europe PubMed Central

5 August 2017

1 reference

ORCID Public Data File 2021

author name string

Steven M Rowe

1

1 reference

Europe PubMed Central

5 August 2017

Bo Liu

2

1 reference

Europe PubMed Central

5 August 2017

Aubrey Hill

3

1 reference

Europe PubMed Central

5 August 2017

Heather Hathorne

4

1 reference

Europe PubMed Central

5 August 2017

Morty Cohen

5

1 reference

Europe PubMed Central

5 August 2017

John R Beamer

6

1 reference

Europe PubMed Central

5 August 2017

Frank J Accurso

7

1 reference

Europe PubMed Central

5 August 2017

Qunming Dong

8

1 reference

Europe PubMed Central

5 August 2017

Claudia L Ordoñez

9

1 reference

Europe PubMed Central

5 August 2017

Anne J Stone

10

1 reference

Europe PubMed Central

5 August 2017

Eric R Olson

11

1 reference

Europe PubMed Central

5 August 2017

John P Clancy

12

1 reference

Europe PubMed Central

5 August 2017

VX06-770-101 Study Group

13

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

26 July 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

7

1 reference

Europe PubMed Central

5 August 2017

e66955

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

26 July 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Small molecules to treat cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

An international randomized multicenter comparison of nasal potential difference techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Sodium channels and cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Detection of cystic fibrosis transmembrane conductance regulator activity in early-phase clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

The epithelium as a target for therapy in cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Airway surface dehydration in cystic fibrosis: pathogenesis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Activation of airway cl- secretion in human subjects by adenosine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis andCFTRStop Mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3724869

8 July 2018

Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

Use of nasal potential difference and sweat chloride as outcome measures in multicenter clinical trials in subjects with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

Reproducibility of nasal potential difference measurements in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

Nasal potential difference measurements in patients with atypical cystic fibrosis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

Cystic fibrosis transmembrane conductance regulator ion channel function testing in recurrent acute pancreatitis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0066955

21 January 2018

A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/23922647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23922647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sweat analysis proficiency testing for cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23922647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nasal potential difference in non-classic cystic fibrosis-long term follow up

1 reference

https://pubmed.ncbi.nlm.nih.gov/23922647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Airway ion transport impacts on disease presentation and severity in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23922647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Phenotype and Genotype of Children with Borderline Sweat Test and Abnormal Nasal Epithelial Chloride Transport

1 reference

https://pubmed.ncbi.nlm.nih.gov/23922647

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0066955

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...866955R

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34901567&oldid=1864343419"